Likewise, the high expression of OR51E1 in somatostatin receptor-negative lung carcinoids and in small intestine neuroendocrine carcinomas makes OR51E1 a potential novel diagnostic biomarker in these types of tumor [27,28]. The gene discussed is OR51E1; the disease is lung carcinoid tumor.